Mortality benefit with antifibrotics in idiopathic pulmonary fibrosis: real world evidence or bias?

被引：6
|
作者：
Suissa, Samy [1 ,2 ,3 ]
Assayag, Deborah [1 ,3 ,4 ]
机构：
[1] McGill Univ, Dept Epidemiol Biostat & Occupat Hlth, Montreal, PQ, Canada
[2] Jewish Gen Hosp, Lady Davis Inst, Ctr Clin Epidemiol, Montreal, PQ, Canada
[3] McGill Univ, Dept Med, Montreal, PQ, Canada
[4] McGill Univ, Hlth Ctr, Div Resp Med, Montreal, PQ, Canada
来源：
EUROPEAN RESPIRATORY JOURNAL | 2021年 / 57卷 / 03期
关键词：
IMMORTAL TIME BIAS;
D O I：
10.1183/13993003.04562-2020
中图分类号：
R56 [呼吸系及胸部疾病];
学科分类号：
摘要：
引用
收藏
页数：3
相关论文
共 50 条
  • [21] Uptake of Antifibrotics for Patients with Idiopathic Pulmonary Fibrosis: 2016-2022
    Shankar, Divya A.
    Hawkins, Finn
    Alysandratos, Konstantinos-Dionysios
    Wilson, Kevin C.
    Walkey, Allan J.
    Bosch, Nicholas A.
    Law, Anica C.
    ANNALS OF THE AMERICAN THORACIC SOCIETY, 2024, 21 (01) : 170 - 173
  • [22] REVIEW OF PATIENT LONGEVITY WHEN MANAGED WITH ANTIFIBROTICS FOR IDIOPATHIC PULMONARY FIBROSIS
    Naqvi, M.
    West, A.
    THORAX, 2021, 76 : A163 - A163
  • [23] Real-World Data on the Course of Idiopathic Pulmonary Fibrosis
    Nathan, Steven D.
    Lee, Joyce S.
    AMERICAN JOURNAL OF MANAGED CARE, 2024, 30 (07): : S107 - S113
  • [24] Occurrence of Idiopathic Pulmonary Fibrosis in Italy: Latest Evidence from Real-World Data
    Iommi, Marica
    Bonifazi, Martina
    Faragalli, Andrea
    Latini, Lara Letizia
    Mei, Federico
    Spazzafumo, Liana
    Skrami, Edlira
    Ferrante, Luigi
    Carle, Flavia
    Gesuita, Rosaria
    INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH, 2022, 19 (05)
  • [25] Antifibrotic Therapy for Idiopathic Pulmonary Fibrosis: Combining Real World and Clinical Trials for Totality of Evidence
    Khor, Yet H.
    CHEST, 2021, 160 (05) : 1589 - 1591
  • [26] Nintedanib in the management of idiopathic pulmonary fibrosis: clinical trial evidence and real-world experience
    Rivera-Ortega, Pilar
    Hayton, Conal
    Blaikley, John
    Leonard, Colm
    Chaudhuri, Nazia
    THERAPEUTIC ADVANCES IN RESPIRATORY DISEASE, 2018, 12
  • [27] NEW TREATMENTS IN IDIOPATHIC PULMONARY FIBROSIS: REAL WORLD EXPERIENCE
    Jo, H.
    Troy, L.
    Corte, P.
    Torzillo, P.
    Webster, S.
    Taylor, N.
    Don, G.
    Corte, T.
    RESPIROLOGY, 2015, 20 : 85 - 85
  • [28] Broad Adoption of Antifibrotics in Idiopathic Pulmonary Fibrosis: Still a Long Way to Go
    Assayag, Deborah
    ANNALS OF THE AMERICAN THORACIC SOCIETY, 2021, 18 (07) : 1115 - 1116
  • [29] Real-World Clinical Effectiveness and Safety of Antifibrotics in Progressive Pulmonary Fibrosis Associated with Rheumatoid Arthritis
    Narvaez, Javier
    Aguilar-Coll, Marti
    Vicens-Zygmunt, Vanesa
    Alegre, Juan Jose
    Bermudo, Guadalupe
    Molina-Molina, Maria
    JOURNAL OF CLINICAL MEDICINE, 2024, 13 (23)
  • [30] IDIOPATHIC PULMONARY FIBROSIS Underestimating treatment benefit of lung transplantation for idiopathic pulmonary fibrosis
    Riddell, P.
    Eaton, D.
    Miller, A. B.
    Wells, A. U.
    Egan, J. J.
    BMJ-BRITISH MEDICAL JOURNAL, 2014, 348
12345